Neoadjuvant Chemoimmunotherapy Does Not Increase Postoperative Morbidity of Pneumonectomy in NSCLC Patients: A Multi-Center Psmanalysis

被引：0
|
作者：
Li, Z. [1 ]
He, W. [1 ]
机构：
[1] Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
pneumonectomy; non-small cell lung cancer; Neoadjuvant chemoimmunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.08D.06
引用
收藏
页码：S570 / S570
页数：1
相关论文
共 50 条
  • [1] Morbidity and mortality of pneumonectomy for lung cancer: Neoadjuvant chemotherapy does not increase the risk of postoperative complications
    Glogowski, M
    Zmijewski, M
    Wlodarczyk, R
    Piech, K
    Turski, M
    Zajda, K
    Kowalski, D
    Murawska, M
    Pietraszek, A
    LUNG CANCER, 2005, 49 : S60 - S60
  • [2] Clinical impact and real-world UK multi-center experience of neoadjuvant chemoimmunotherapy for resectable NSCLC
    Milic, Marina
    Cheung, Maggie
    Bolnykh, Lakov
    Newsom-Davis, Thomas
    Januszewski, Adam
    Ahmad, Tanya
    Papadatos-Pastos, Dionysis
    Lee, Siow Ming
    Jamal-Hanjani, Mariam
    Forster, Martin
    Benafif, Sarah
    LUNG CANCER, 2025, 200 : 53 - 54
  • [3] Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?
    Mungo, B.
    Molena, D.
    Stem, M.
    Yang, S. C.
    Battafarano, R. J.
    Brock, M. V.
    Lidor, A. O.
    DISEASES OF THE ESOPHAGUS, 2015, 28 (07) : 644 - 651
  • [4] Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity?
    Tabira Y.
    Okuma T.
    Kondo K.
    Yoshioka M.
    Mori T.
    Tanaka M.
    Nakano K.
    Kitamura N.
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 1999, 47 (8): : 361 - 367
  • [5] Thoracic Morbidity and Mortality System in Analysis of Postoperative Complications After Pneumonectomy in NSCLC Patients
    Pikin, O.
    Ryabov, A.
    Glushko, V.
    Kolbanov, K.
    Amiraliev, A.
    Barmin, V.
    Alexandrov, O.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2351 - S2351
  • [6] Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?
    Cooper, Amanda B.
    Parmar, Abhishek D.
    Riall, Taylor S.
    Hall, Bruce L.
    Katz, Matthew H. G.
    Aloia, Thomas A.
    Pitt, Henry A.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (01) : 80 - 87
  • [7] Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?
    Amanda B. Cooper
    Abhishek D. Parmar
    Taylor S. Riall
    Bruce L. Hall
    Matthew H. G. Katz
    Thomas A. Aloia
    Henry A. Pitt
    Journal of Gastrointestinal Surgery, 2015, 19 : 80 - 87
  • [8] Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?
    Cooper, Amanda
    Parmar, Abhishek
    Hall, Bruce L.
    Katz, Matthew H.
    Fleming, Jason B.
    Aloia, Thomas
    Riall, Taylor S.
    Pitt, Henry
    GASTROENTEROLOGY, 2014, 146 (05) : S1016 - S1016
  • [9] Neoadjuvant chemoradiotherapy followed by esophagectomy does not increase morbidity in patients over 70
    Blom, R. L. G. M.
    van Heijl, M.
    Klinkenbijl, J. H. G.
    Bergman, J. J. G. H. M.
    Wilmink, J. W.
    Richel, D. J.
    Hulshof, M. C. C. M.
    Reitsma, J. B.
    Busch, O. R. C.
    Henegouwen, M. I. van Berge
    DISEASES OF THE ESOPHAGUS, 2013, 26 (05) : 510 - 516
  • [10] Major pathologic response as a prognostic surrogate in esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy/ chemoimmunotherapy: A multi-center cohort study
    Hong, Zhinuan
    Xie, Shuhan
    Xu, Hui
    Ke, Sunkui
    Liu, Wenyi
    Huang, Shijie
    Chen, Shuchen
    Xie, Jinbiao
    Xu, Jinxin
    Kang, Mingqiang
    EJSO, 2025, 51 (02):
12345